NNOX on the 15 minute chart is on a 100% move due to FDA clearance of its new 3D technology for Xrays. This will revolutionize Xrays for the medical field like MRIs did when they come out compared with CT Scan. This is an Israeli company whose technology will be inexpensive and will potentially be adapted globally. The market is measured in multiple billions...
KemPharm Announces FDA Approval of AZSTARYS™ (serdexmethylphenidate and dexmethylphenidate capsules, for oral use, CII), A New Once-Daily Treatment for ADHD Corium, Inc. will lead the commercialization of AZSTARYS per the definitive collaboration and license agreement. Corium expects to make AZSTARYS commercially available in the U.S. as early as the second...
We just checked pharmacies around the North East PALFORZIA peanut allergy drug is available at CVS Pharmacy and is being filled at CVS Pharmacy CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations with over 9,600 pharmacies throughout the United States. Its parent company ranks as the 7th largest U.S. corporation by...
BE CAREFUL!! I'm getting bad vibes on the news for tomorrow in this one. This is based on my dowsing work and it suggests a drop of 38%. That would rock it down to about $42.50 FYI I don't know anything about the fundamentals or background on this pending approval, and I really don't know anything about the company, nor do I care. I'm not super confident yet in...
We are really liking the chart on $AMPE. You have the rounding bottom and there looks to be accumulation going on. Currently trading at $.62 a share, the 52-week low is $.35 a share. We believe $AMPE has breakout written all over it and there is an upcoming catalyst that can send the stock flying higher. The company is due to hear from the FDA shortly. Here's...
Summary PKTX is where CSBR was 3 years ago. PKTX's AAGP molecule is life changing. Data is coming. With that comes higher stock price. Those of you who have been following me the last few years, because of my call on Champions Oncology, CSBR, know that I have been predicting that ProtoKinetix PKTX is destined to be my next CSBR. The dynamics of each company...
Will Women get an F&DA approval for their VIAGRA?? Good entry with LT target 4-5 if approved. This chart is for own use. Viewers come to own conclusions and appreciate comments and learning thoughts.
EDAP has recieved FDA clearance on its prostate device. With a price target of $6 this has room to run. Shorts could get trapped. A mourning dip got caused some panic but it appears to be holding the $3.70 range and looking to setup for another break out after the rsi cools down a bit.